Each Sunday we feature a highlight reel of various articles posted on our website that week.

Venclexta-azacitidine combination offered better responses with less hospitalization and lower symptom burden compared with ...

He also discussed how linvoseltamab could fit into care for newly diagnosed patients. With several treatment options already available, he said linvoseltamab may become another strong choice, ...

Robert Orlowski, M.D., Ph.D., of the MD Anderson Cancer Center shared early results from the LINKER-MM1 trial with Managed Healthcare Executive, which is testing linvoseltamab in people newly ...

Researchers said future studies could help refine the use of Jaypirca alone or in combination with other therapies as a frontline treatment. She added that they are also continuing to investigate ...

The chief medical officer of Genetix Biotherapeutics, formerly known as Bluebird bio, discusses timelines and operational ...

From 2017 to 2024, newly diagnosed multiple myeloma (MM) patients rapidly received quadruplet therapies over triplets, with ...

Imfinzi is the first perioperative immunotherapy approved for resectable gastric/GEJ cancers, offering a new treatment ...

In this episode of his “Conversations With Perry and Friends” podcast, Perry Cohen, Pharm.D., a member of the Managed ...

In this interview, Susan Kellogg-Spadt, Ph.D., the director of female sexual medicine at the Center for Pelvic Medicine at ...

The CDC’s Advisory Committee on Immunization Practices (ACIP) began its December 4 and 5, 2025, meeting today, launching two ...

About one-third of families with a child undergoing treatment for acute lymphoblastic leukemia experienced catastrophic income loss during therapy, with many developing new material hardships over the ...